In VivoImaging of Tumor Physiological, Metabolic, and Redox Changes in Response to the Anti-Angiogenic Agent Sunitinib: Longitudinal Assessment to Identify Transient Vascular Renormalization
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.